Dv Biomed Co Stock Fundamentals
| 6539 Stock | TWD 66.60 0.20 0.30% |
DV Biomed Co fundamentals help investors to digest information that contributes to DV Biomed's financial success or failures. It also enables traders to predict the movement of 6539 Stock. The fundamental analysis module provides a way to measure DV Biomed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DV Biomed stock.
6539 |
DV Biomed Co Company Current Valuation Analysis
DV Biomed's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current DV Biomed Current Valuation | 3.68 B |
Most of DV Biomed's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DV Biomed Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, DV Biomed Co has a Current Valuation of 3.68 B. This is 74.38% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all Taiwan stocks is 77.86% higher than that of the company.
DV Biomed Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DV Biomed's current stock value. Our valuation model uses many indicators to compare DV Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DV Biomed competition to find correlations between indicators driving DV Biomed's intrinsic value. More Info.DV Biomed Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DV Biomed Co is roughly 2.66 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DV Biomed's earnings, one of the primary drivers of an investment's value.6539 Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DV Biomed's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DV Biomed could also be used in its relative valuation, which is a method of valuing DV Biomed by comparing valuation metrics of similar companies.DV Biomed is currently under evaluation in current valuation category among its peers.
6539 Fundamentals
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 | |||
| Profit Margin | 16.64 % | |||
| Operating Margin | 14.88 % | |||
| Current Valuation | 3.68 B | |||
| Shares Outstanding | 59.26 M | |||
| Price To Earning | 13.49 X | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 1.81 B | |||
| Gross Profit | 925.51 M | |||
| EBITDA | 448.99 M | |||
| Net Income | 301.4 M | |||
| Cash And Equivalents | 538.29 M | |||
| Cash Per Share | 9.14 X | |||
| Total Debt | 249.93 M | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 2.32 X | |||
| Book Value Per Share | 20.43 X | |||
| Cash Flow From Operations | 463.36 M | |||
| Earnings Per Share | 5.04 X | |||
| Number Of Employees | 316 | |||
| Beta | 0.48 | |||
| Market Capitalization | 4.03 B | |||
| Z Score | 9.6 | |||
| Last Dividend Paid | 1.64 |
About DV Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DV Biomed Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DV Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DV Biomed Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company was founded in 2011 and is based in Taipei, Taiwan. UnicoCell operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
Pair Trading with DV Biomed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DV Biomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will appreciate offsetting losses from the drop in the long position's value.Moving together with 6539 Stock
Moving against 6539 Stock
| 0.68 | 2891 | CTBC Financial Holding | PairCorr |
| 0.67 | 2881B | Fubon Financial Holding | PairCorr |
| 0.63 | 2881A | Fubon Financial Holding | PairCorr |
| 0.58 | 2891B | CTBC Financial Holding | PairCorr |
| 0.57 | 2882B | Cathay Financial Holding | PairCorr |
The ability to find closely correlated positions to DV Biomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DV Biomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DV Biomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DV Biomed Co to buy it.
The correlation of DV Biomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DV Biomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DV Biomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DV Biomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for 6539 Stock Analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.